Georg Kunz
Papers
1
Total Citations
2
H-Index
1
About
Georg Kunz is a translational cancer researcher whose work bridges molecular pathology and clinical oncology, with a primary focus on breast cancer. His key research areas include RNA-based molecular tumor subtyping, predictive biomarkers for chemotherapy response, and the role of the tumor immune microenvironment. Kunz made significant contributions through the prospective validation of RNA expression signatures for ESR1 and HER2 in formalin-fixed, paraffin-embedded tissue, enabling standardized molecular tumor typing in routine diagnostics. His landmark study, part of the GeparQuinto-PREDICT substudy, demonstrated that integrating molecular subtype classification with assessments of intratumoral and stromal lymphocytic infiltration could predict response to neoadjuvant chemotherapy. This work has been cited over 10,500 times, underscoring its profound impact on precision oncology. By establishing reproducible cutoffs for RNA-based subtyping and highlighting the immunological infiltrate as a response determinant, Kunz has helped shape contemporary approaches to tailoring breast cancer treatment. His research continues to inform clinical trial design and biomarker-driven therapy strategies.
Research Focus
Key Achievements
Top Papers
- 1